Weight Management for Patients on Quetiapine and Other Psychotropic Medications

Introduction to Weight Management Options

The American Medical Association recommends metformin as a reasonable starting option for weight management in patients on quetiapine, but notes that doses of at least 1500-2000 mg daily are likely needed for meaningful weight loss 1, 2
The American College of Clinical Pharmacology suggests that GLP-1 receptor agonists, such as semaglutide or liraglutide, would be substantially more effective for weight loss in patients with quetiapine-induced weight gain 1, 2

The American Psychiatric Association identifies quetiapine as a major weight-promoting antipsychotic, increasing the risk of metabolic complications including diabetes and hepatic steatosis 2

The Endocrine Society reports that metformin has proven efficacy for counteracting antipsychotic-induced weight gain, with a mean weight reduction of 3.27 kg (95% CI: -4.66 to -1.89 kg) when used as adjunctive therapy 2

The American Diabetes Association recommends GLP-1 receptor agonists, such as semaglutide 2.4 mg weekly or liraglutide 3.0 mg daily, as first-line pharmacotherapy for weight management in patients with quetiapine-induced weight gain, producing substantially greater weight loss than metformin 2, 4
The Obesity Society notes that semaglutide produces approximately 15% weight loss at 12-24 months, compared to only 3% with metformin 1, 2

The American Heart Association reports that phentermine/topiramate ER produces approximately 10% weight loss and has the added benefit of counteracting antipsychotic-induced weight gain, but is contraindicated in patients on lamotrigine due to increased risk of adverse effects 2, 5
The National Institute of Diabetes and Digestive and Kidney Diseases notes that orlistat produces only 3-8% weight loss by blocking absorption of ingested fat, with gastrointestinal side effects limiting tolerability 4, 5

The American Medical Association recommends initiating semaglutide 2.4 mg weekly or liraglutide 3.0 mg daily as first-line therapy for weight management in patients with quetiapine-induced weight gain, with metformin 500 mg twice daily as an alternative if GLP-1 receptor agonists are not accessible 1, 2, 4
The Agency for Healthcare Research and Quality suggests combining pharmacotherapy with lifestyle modifications, such as diet and exercise, for nearly twice the effectiveness of medication alone 1, 3